Cellares to provide proof-of-concept manufacturing for a key BMS CAR-T cell therapy Cellares' proprietary Cell Shuttle is a cost-efficient, reliable, fully automated, and highly scalable manufacturing ...

Cellares, an Integrated Development and Manufacturing Organization (IDMO), concluded the Technology Adoption Program (TAP) on its automated cell therapy manufacturing Cell Shuttle™ for resecabtagene ...

Proof-of-concept manufacturing to be provided by Cellares for a key Lyell CAR T-cell therapy using Cellares' exclusive Cell Shuttle Collaboration to evaluate potential utilization of the Cell Shuttle ...

When introducing new vehicle models, each launch can demand extensive reconfiguration of existing production lines. Timing is ...

Cellular Origins, Resolution Therapeutics, and Cell and Gene Therapy Catapult (CGT Catapult) say they set up a project aimed at using novel technologies to deliver a hyper-efficient, fully automated, ...

Frontline operations software startup Tulip Interfaces Inc. said today it has raised $120 million in a late-stage funding round that brings its valuation to more than $1.3 billion, joining the ranks ...

KUKA Group uses simulation to cut risks, speed production, and boost efficiency in automation systems worldwide ...